Bluebird bags EU conditional marketing authorisation for Zynteglo by Anna Smith | Jun 4, 2019 | News | 0 The authorisation for the inherited blood disorder marks bluebird’s first ever drug approval. Read More
Bluebird’s Zynteglo kicks off first Amsterdam CHMP recommendations by Anna Smith | Apr 1, 2019 | News | 0 The European Medicines Agency’s CHMP positive opinions are sparse this time around. Read More